Article
The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis.
BMC cancer - 18 Feb 2016
Kim Hae Su, Heo Jin Seok, Lee Jeeyun, Lee Ji Yun, Lee Min-Young, Lim Sung Hee, Lee Woo Yong, Kim Seok Hyung, Park Yoon Ah, Cho Yong Beom, Yun Seong Hyeon, Kim Seung Tae, Park Joon Oh, Lim Ho Yeong, Choi Yong Soo, Kwon Woo Il, Kim Hee Cheol, Park Young Suk
Abstract excerpt
BACKGROUND: KRAS mutations are common in colorectal cancer (CRC). The role of KRAS mutation status as a prognostic factor remains controversial, and most large population-based cohorts usually consist of patients with non-metastatic CRC. We evaluated the impact of KRAS mutations on the time to recurrence (TTR) and overall survival (OS) in patients with metastatic CRC who underwent curative surgery with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
